Carl Zeiss Meditec A G 

€25.8
461
-€3.8-12.84% Thursday 11:43

Statistics

Day High
25.8
Day Low
25.8
52W High
65
52W Low
23.2
Volume
3
Avg. Volume
-
Mkt Cap
0
P/E Ratio
-
Dividend Yield
2.2%
Dividend
0.57

Upcoming

Dividends

2.2%Dividend Yield
Apr 26
€0.57
Apr 25
€0.6
Apr 24
€1.09
Apr 23
€1.1
Apr 22
€0.89
10Y Growth
4.12%
5Y Growth
N/A
3Y Growth
-19.88%
1Y Growth
-4.98%

Earnings

12MayExpected
Q1 2024
Q3 2025
Q1 2026
0.47
0.63
0.79
0.94
Expected EPS
N/A
Actual EPS
0.47249456942400003

People Also Follow

This list is based on the watchlists of people on Stock Events who follow AFXA.MU. It's not an investment recommendation.

Competitors

This list is an analysis based on recent market events. It's not an investment recommendation.
Align Technology
ALGN
Mkt Cap11.68B
Align Technology competes in the dental and orthodontic sector, overlapping with Carl Zeiss Meditec's offerings in dental microscopy and imaging technologies.
Intuitive Surgical
ISRG
Mkt Cap155.16B
Intuitive Surgical is a direct competitor in the medical devices sector, particularly in advanced surgical systems where Carl Zeiss Meditec also operates with its visualization solutions.
Medtronic
MDT
Mkt Cap100.91B
Medtronic competes across multiple healthcare sectors, including surgical technologies and imaging, areas where Carl Zeiss Meditec is also active.
Boston Scientific
BSX
Mkt Cap85.88B
Boston Scientific competes in the medical devices market, including interventional medicine and imaging, directly competing with Carl Zeiss Meditec's product lines.
Stryker
SYK
Mkt Cap121.33B
Stryker operates in the medical technology field, offering products in orthopaedics, surgery, and neurotechnology, which competes with Carl Zeiss Meditec's surgical and visualization equipment.
Abbvie
ABBV
Mkt Cap381.1B
AbbVie, through its acquisition of Allergan, competes in the eye care sector, particularly in ophthalmic products, directly challenging Carl Zeiss Meditec's offerings.
Johnson & Johnson
JNJ
Mkt Cap564.11B
Johnson & Johnson, through its medical devices division, competes in the surgical and vision care markets, overlapping with Carl Zeiss Meditec's product range.
Danaher
DHR
Mkt Cap121.74B
Danaher, with its dental and life sciences segments, competes in the medical imaging and diagnostics field, areas where Carl Zeiss Meditec is also active.
Zimmer Biomet
ZBH
Mkt Cap16.54B
Zimmer Biomet competes in the musculoskeletal healthcare sector, offering products that can be used in surgeries where Carl Zeiss's visualization technologies are applicable.
Resmed
RMD
Mkt Cap30.18B
ResMed competes in the health sector with its sleep and respiratory care products, indirectly competing with Carl Zeiss Meditec's focus on medical technology and devices.

About

Carl Zeiss Meditec AG operates as a medical technology company in Germany, rest of Europe, North America, and Asia. It operates in two segments, Ophthalmology and Microsurgery. The Ophthalmology segment offers products and solutions for the diagnosis and treatment of chronic eye diseases, including slit lamps, refractometers, and tonometers; optical coherence tomography and fundus cameras for retina examination; functional glaucoma diagnostic devices (perimeters); surgical ophthalmology products comprising surgical microscopes, biometers, and phacoemulsification and vitrectomy equipment; intraocular lenses for cataract surgery; and systems and consumables for laser eye surgery that include the VISUMAX femtosecond laser, which enables minimally invasive correction of vision defects using lenticular extraction, as well as digital products for the storage, analysis, and sharing of clinical data. The Microsurgery segment provides products and solutions for minimally invasive surgical treatments, including surgical visualization, interoperative radiotherapy, interoperative pathology, special surgical instruments, and digital solutions, as well as the ZEISS Tumor Workflow, a cross-product workflow solution. It serves physicians in various fields and hospitals. The company was founded in 1846 and is headquartered in Jena, Germany. Carl Zeiss Meditec AG operates as a subsidiary of ZEISS Group.
Show more...
CEO
ISIN
US14218T1051

Listings

0 Comments

Share your thoughts

FAQ

What is Carl Zeiss Meditec A G stock price today?
The current price of AFXA.MU is €25.8 EUR — it has decreased by -12.84% in the past 24 hours. Watch Carl Zeiss Meditec A G stock price performance more closely on the chart.
What is Carl Zeiss Meditec A G stock ticker?
Depending on the exchange, the stock ticker may vary. For instance, on exchange Carl Zeiss Meditec A G stocks are traded under the ticker AFXA.MU.
Is Carl Zeiss Meditec A G stock price growing?
AFXA.MU stock has risen by +0% compared to the previous week, the month change is a -7.86% fall, over the last year Carl Zeiss Meditec A G has showed a -56.27% decrease.
When is the next Carl Zeiss Meditec A G earnings date?
Carl Zeiss Meditec A G is going to release the next earnings report on December 10, 2026.
What were Carl Zeiss Meditec A G earnings last quarter?
AFXA.MU earnings for the last quarter are 0.47 EUR per share, whereas the estimation was N/A EUR resulting in a N/A surprise. The estimated earnings for the next quarter are N/A EUR per share.
Does Carl Zeiss Meditec A G pay dividends?
Yes, AFXA.MU dividends are paid annual. The last dividend per share was 0.57 EUR. As of today, Dividend Yield (FWD)% is 2.2%.
In which sector is Carl Zeiss Meditec A G located?
Carl Zeiss Meditec A G operates in the Other sector.
When did Carl Zeiss Meditec A G complete a stock split?
Carl Zeiss Meditec A G has not had any recent stock splits.